BFC Planning’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.78M Sell
28,604
-1,398
-5% -$88.4K 0.07% 266
2026
Q2
$1.73M Sell
30,002
-1,512
-5% -$86.8K 0.07% 271
2026
Q1
$1.91M Sell
31,514
-2,560
-8% -$149K 0.09% 235
2025
Q4
$1.84M Buy
34,074
+20,674
+154% +$995K 0.08% 237
2025
Q3
$604K Sell
13,400
-140
-1% -$6.54K 0.04% 335
2025
Q2
$627K Sell
13,540
-5,193
-28% -$255K 0.05% 309
2025
Q1
$1.14M Buy
18,733
+1,104
+6% +$64.4K 0.1% 181
2024
Q4
$997K Buy
17,629
+3,759
+27% +$210K 0.08% 204
2024
Q3
$718K Buy
+13,870
New +$651K 0.06% 262

Other funds holding BMY

BFC Planning's BMY Position: Q3 2026 in Review

BFC Planning reduced its Bristol-Myers Squibb (BMY) stake by 4.7% in Q3 2026, selling an estimated $88.4K and leaving 28,604 shares worth $1.78M. The position accounts for 0.07% of the portfolio, ranked #266.

BFC Planning first reported a position in BMY in Q3 2024 and has held it in 9 quarters since. The position peaked at $1.91M in Q1 2026. 2,253 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • BFC Planning held 28,604 shares of Bristol-Myers Squibb worth $1.78M as of Q3 2026.
  • BFC Planning sold 1,398 Bristol-Myers Squibb shares in Q3 2026, an estimated $88.4K.
  • Bristol-Myers Squibb made up 0.07% of BFC Planning's portfolio in Q3 2026, its #266 holding.
  • BFC Planning first reported a position in Bristol-Myers Squibb in Q3 2024 and has held it in 9 quarters since.
  • BFC Planning's Bristol-Myers Squibb position peaked at $1.91M in Q1 2026.
  • 2,253 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.